POCI logo

PRECISION OPTICS CORP INC

POCINASDAQ
๐Ÿ† #4226 by market capEarnings Feb 15US Equity
$4.12โ–ผ $0.06 (โˆ’1.44%)
Market closed ยท at close
๐Ÿ””
Track POCI
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ผ 1.4%
7dโ–ผ 21.9%
14dโ–ผ 13.3%
30dโ–ผ 5.3%
ytdโ–ผ 1.2%
1yโ–ผ 9.1%
๐ŸฆMarket Cap
$45M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
65.2%
High Growth
๐Ÿ“ŠGross Margin
17.2%
Thin
๐Ÿ’ตFCF Margin
2.1%
Thin
โš–๏ธP/S Ratio
1.4x
Cheap
Otter Score
โ€”
Insufficient data

Trading Snapshot

Day Range
$4.10 โ€“ $4.12
52-Week Range
$3.55 โ€“ $6.15
Volume (shares)
932
Avg Volume (shares)
โ€”
Shares Outstanding
11.0M
Next Earnings
2027-02-15

Fundamentals Snapshot

Annual Revenue
โ€”
Last Q Revenue
โ€”
P/E Ratio
โ€”
P/S Ratio
1.4x
EPS (TTM)
$-0.47
Dividend Yield
โ€”
POCI logo

PRECISION OPTICS CORP INC

POCI
Financial Trends

Financial history unavailable.

StockOtter ยท stockotter.space

About PRECISION OPTICS CORP INC

Precision Optics Corporation, Inc. (POCI) specializes in the engineering, manufacturing, and sale of advanced optical and illumination systems, along with their complementary components. Its main operational regions are the United States and the European Economic Area. The company's offerings include medical instruments such as various types of endoscopes and endocouplers. Moreover, POCI provides bespoke imaging and lighting solutions, encompassing high-precision Microprecision lenses, miniature medical cameras, and cutting-edge 3D endoscopes, all designed for application in minimally invasive surgical procedures carried out by hospitals and healthcare professionals. Beyond its medical division, POCI also produces individual parts and integrated assemblies for industrial and military purposes. POCI markets its medical device portfolio primarily to other corporations within the medical technology sector. Established in 1982, the firm's headquarters are located in Gardner, Massachusetts.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Insufficient data
โ€”/100

Analyst Ratings

โ“˜
Consensus
Buy
7 analysts
Strong Buy2
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Nov 2026

Latest News & Updates

News unavailable.